Investor Presentation
Q2 FY26
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Chemicals
Biotechnology
3,584 Cr
High Risk
23.3
74.2
0.1
2.6
550.00
388.80
Sales CAGR
1Y
55.94%
3Y
—
5Y
—
10Y
—
Profit CAGR
1Y
360.99%
3Y
—
5Y
—
10Y
—
ROE
TTM
10.96%
3Y
16.50%
5Y
—
10Y
—
ROCE
TTM
10.33%
3Y
12.04%
5Y
—
10Y
—
Bearish
2
Neutral
6
Bullish
6
Bearish
17
Neutral
22
Bullish
7
Bearish
15
Neutral
16
Bullish
1
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Performance
STEADY PERFORMER
Valuation
REASONABLE
Growth
STABLE
Profitability
MODERATE MARGIN
Technicals
Neutral
Risk
HIGH RISK
Market Cap
₹ 3,584 Cr
P/E
23.33